We are live on ! Find out more
PHVS icon

Pharvaris

20 hedge funds and large institutions have $494M invested in Pharvaris in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $397M → $494M (+$96.9M)

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

1.98% more ownership

Funds ownership: 65.46%67.43% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

9% less funds holding

Funds holding: 2220 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.34%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
1
Increased
7
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

PHVS Hedge Fund Activity: Q2 2022 in Review

20 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q2 2022, worth a combined $494M — up 24% from $397M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PHVS and 1 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was 5AM Venture Management, opening a new position worth an estimated $11M. The largest seller was Deerfield Management, cutting an estimated $7.21M.

  • 20 institutional investors held Pharvaris (PHVS) as of Q2 2022, down from 22 in Q1 2022.
  • Funds reported $494M of Pharvaris stock for Q2 2022, up 24% quarter-over-quarter.
  • 1 fund opened new Pharvaris positions in Q2 2022 and 3 closed out, a net change of -2 holders.
  • The largest Pharvaris buyer in Q2 2022 was 5AM Venture Management, an estimated $11M added.
  • The largest Pharvaris seller in Q2 2022 was Deerfield Management, an estimated $7.21M sold.

Based on aggregated 13F filings for Q2 2022.